Announcement
20 Apr 2023
In April 2023, U.S. BARDA provided funding to support the development and FDA clearance of a SARS-CoV-2 and influenza A and B test.
Source
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
Implementation date
20 Apr 2023
Revocation date:
No revocation date
On 20 April 2023, the Biomedical Advanced Research and Development Authority (BARDA) of the United States announced providing USD 19.6 million in funding to Aptitude Medical Systems Inc to support ...
See all
This state act is not part of any Thread yet.